[{"arm_notes": "", "treatment_id": null, "treatment_name": "Experimental group: 250 patients will receive EF168\n orally; 3 x daily; for 5 days; orally.* Confidential treatmentControl group: 250 patients will receive oral placebo; 3 times a day; for 5 days; orally.;Drug;D27.505.954.122", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": 447, "treatment_name": "Ef168", "treatment_type": "Others pharmacological treatment", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]

[{"arm_notes": "", "treatment_id": null, "treatment_name": "Experimental group: 250 patients will receive EF168\n orally; 3 x daily; for 5 days; orally.* Confidential treatmentControl group: 250 patients will receive oral placebo; 3 times a day; for 5 days; orally.;Drug;Anti-Infective Agents", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]